Series C Funding
BenchSci Raises $63 Million Series C to Solve Pharma's Biggest R&D Challenges with AI-Powered Software Platform
BenchSci
PR-M01-22-15Jan 24, 2022
Financing
HiFiBiO Therapeutics Closes $67 Million Series C Financing to Build on Recent Success and Advance Pipeline of Novel Antibody Drugs for Cancer and Autoimmune Disorders
Nice Insight
PR-M08-19-NI-088Aug 30, 2019
Series C Financing
Sirnaomics Closes $47 Million Series C Financing to Develop RNAi Therapeutics for Treatment of Cancer and Fibrotic Diseases
Sirnaomics, Inc.
PR-M04-19-NI-091Apr 30, 2019